Ashley Koegel
About Ashley Koegel
Ashley Koegel is the Executive Medical Director at Bristol Myers Squibb and an Assistant Professor at the University of California, San Francisco, with a strong background in hematologic malignancies and immunotherapies.
Professional Experience
Ashley Koegel serves as the Executive Medical Director at Bristol Myers Squibb, based in the San Francisco Bay Area. In this capacity, she leads the Early Clinical Development Autoimmune Cell Therapy Pillar. Her prior roles at Bristol Myers Squibb include Senior Medical Director from 2022 to 2023 for 1 year, and Medical Director from 2019 to 2022 for 3 years. Additionally, she worked at Celgene as Medical Director for 2 months in 2019. Alongside her work at Bristol Myers Squibb, Ashley holds an academic role as an Assistant Professor at the University of California, San Francisco (UCSF).
Medical Background and Education
Ashley Koegel holds an MD degree from Stanford University School of Medicine, where she studied from 2008 to 2013. Prior to that, she earned a Bachelor of Science in Biochemistry from UCLA, studying from 2003 to 2008. Her medical and hematology-oncology training includes experiences at Stanford University, Harvard University, and UCSF. This extensive training underpins her expertise in hematologic malignancies and immunotherapies.
Academic Roles
Ashley Koegel currently works as an Assistant Professor at UCSF and a Pediatric Hematologist/Oncologist at UCSF Medical Center. She previously held the position of Clinical Instructor at UCSF from 2019 to 2021 and served as a Clinical Fellow from 2016 to 2019. Her postdoctoral research work includes a fellowship at the Laboratory of Wendell Lim at UCSF from 2017 to 2019.
Early Career Development
Before her current roles, Ashley Koegel undertook a Residency in General Pediatrics at Boston Children's Hospital from 2013 to 2016. This foundational experience helped shape her clinical acumen and prepared her for a career focusing on hematologic malignancies and cellular therapies.
Research and Clinical Expertise
Ashley Koegel has a strong research background with skills in Clinical Research, Hematology, Cellular Therapies, and Immunology. Her involvement in early clinical development and immuno-oncology positions her as a key contributor in the field of hematologic malignancies and autoimmune cell therapies.